Back to search results
NCT01803906

Tissue Sample Study for Mitochondrial Disorders

Enrolling by Invitation
Not specifiedAll AgesObservational
Columbia University
~6,900 participants
Updated 2026-01-07 on ClinicalTrials.gov

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of patients with reduced respiratory chain enzyme levels
Measured over Up to 2 years

Conditions

Mitochondrial Disorders
Mitochondrial Disease
Melas
Kearns Sayer
NARP
MNGIE
LHON
Mitochondrial Depletion Syndrome
Leigh's Disease

Explore related trials

Kearns-Sayre SyndromeLeber Hereditary Optic AtrophyLeigh DiseaseMELAS SyndromeMitochondrial diseaseMitochondrial DNA Depletion SyndromesMitochondrial Neurogastrointestinal EncephalopathyNARP syndromeGenetic mutation

Where it's being run

1 sites across 1 states
New York1

Study leadership

  • Michio Hirano, MD · PRINCIPAL_INVESTIGATOR · Columbia University

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients suspected of having a mitochondrial disorder
Patients who may carry a genetic mutation or be related to someone with a genetic mutation which may cause a mitochondrial disorder

Exclusion

Patients who are not suspected of having a mitochondrial disorder

What this trial measures

  • Number of patients with reduced respiratory chain enzyme levelsUp to 2 years

    Biochemical studies involving mitochondrial function. The levels will be compared to normal levels.